ROCURONIUM

ROCURONIUM was reported 12126 times

ROCURONIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AIRWAY PEAK PRESSURE 3 0.5000
1 NEGATIVE PRESSURE PULMONARY OEDEMA 42 0.4286
2 BONE CEMENT IMPLANTATION SYNDROME 3 0.3750
3 ANAESTHETIC COMPLICATION NEUROLOGICAL 268 0.2958
4 TRIGEMINO-CARDIAC REFLEX 23 0.2840
5 BISPECTRAL INDEX DECREASED 3 0.2500
6 MYOGLOBIN URINE PRESENT 53 0.2154
7 RECURRENCE OF NEUROMUSCULAR BLOCKADE 34 0.1988
8 NEUROMUSCULAR BLOCK PROLONGED 73 0.1978
9 MECHANICAL VENTILATION COMPLICATION 29 0.1946
10 AIRWAY PEAK PRESSURE INCREASED 28 0.1842
11 NEUROMUSCULAR BLOCKADE 40 0.1786
12 END-TIDAL CO2 INCREASED 7 0.1522
13 NEUROMUSCULAR BLOCKING THERAPY 5 0.1515
14 CATECHOLAMINE CRISIS 5 0.1351
15 ISOIMMUNE HAEMOLYTIC DISEASE 5 0.1316
16 PSEUDOCHOLINESTERASE DEFICIENCY 8 0.1231
17 CHEST WALL RIGIDITY 6 0.0938
18 END-TIDAL CO2 DECREASED 4 0.0851
19 HYPERTHERMIA MALIGNANT 126 0.0846
20 AIRWAY COMPLICATION OF ANAESTHESIA 22 0.0837
21 INSPIRATORY CAPACITY DECREASED 23 0.0830
22 TRYPTASE DECREASED 4 0.0784
23 THERAPEUTIC RESPONSE PROLONGED 7 0.0745
24 VASCULAR ACCESS MALFUNCTION 4 0.0741
25 BURKHOLDERIA TEST POSITIVE 9 0.0726
26 POSTOPERATIVE DELIRIUM 14 0.0707
27 DELAYED RECOVERY FROM ANAESTHESIA 62 0.0654
28 OESOPHAGEAL INTRAMURAL HAEMATOMA 6 0.0571
29 APGAR SCORE ABNORMAL 6 0.0566
30 SUBDURAL EFFUSION 5 0.0543
31 ACCELERATED IDIOVENTRICULAR RHYTHM 8 0.0541
32 PROCEDURAL HYPOTENSION 40 0.0470
33 FOETAL ANAEMIA 6 0.0458
34 ANAESTHETIC COMPLICATION PULMONARY 4 0.0449
35 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 5 0.0446
36 OXIDATIVE STRESS 4 0.0426
37 CORYNEBACTERIUM TEST POSITIVE 3 0.0423
38 FEEDING INTOLERANCE 19 0.0421
39 HARLEQUIN SYNDROME 3 0.0411
40 TRACHEAL INJURY 6 0.0408
41 BRACHIAL PLEXOPATHY 9 0.0407
42 HAEMODILUTION 4 0.0404
43 UNWANTED AWARENESS DURING ANAESTHESIA 13 0.0396
44 PHAEOCHROMOCYTOMA CRISIS 8 0.0377
45 PULMONARY HYPERTENSIVE CRISIS 10 0.0369
46 VOCAL CORD DYSFUNCTION 18 0.0365
47 ALKALOSIS HYPOCHLORAEMIC 5 0.0357
48 NECROTISING SOFT TISSUE INFECTION 8 0.0346
49 VENTRICULAR ASYSTOLE 6 0.0345
50 ALLERGIC TRANSFUSION REACTION 5 0.0331
51 LARYNGEAL OBSTRUCTION 6 0.0328
52 ALLERGY TEST NEGATIVE 5 0.0321
53 BLOOD CATECHOLAMINES INCREASED 4 0.0320
54 CARCINOID CRISIS 7 0.0310
55 FUNGAL DISEASE CARRIER 3 0.0297
56 HYPERDYNAMIC LEFT VENTRICLE 7 0.0285
57 PARKINSONISM HYPERPYREXIA SYNDROME 5 0.0279
58 DECORTICATE POSTURE 3 0.0268
59 SICK LEAVE 6 0.0267
60 HYPOCAPNIA 11 0.0263
61 DRUG HALF-LIFE INCREASED 3 0.0263
62 MATERNAL EXPOSURE DURING DELIVERY 26 0.0262
63 WRIST SURGERY 23 0.0246
64 THERAPEUTIC PRODUCT EFFECT PROLONGED 11 0.0243
65 CHEYNE-STOKES RESPIRATION 6 0.0242
66 NEONATAL RESPIRATORY DEPRESSION 8 0.0241
67 KOUNIS SYNDROME 54 0.0238
68 CORONARY ARTERY EMBOLISM 7 0.0236
69 ATRIOVENTRICULAR DISSOCIATION 5 0.0234
70 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 24 0.0226
71 MYOTONIA 5 0.0225
72 MYOCARDIAL STUNNING 3 0.0224
73 SPINAL CORD OEDEMA 8 0.0216
74 BANDAEMIA 3 0.0204
75 DIABETES INSIPIDUS 49 0.0203
76 MYXOEDEMA COMA 6 0.0197
77 COMPLICATIONS OF TRANSPLANTED LIVER 7 0.0194
78 SUBCUTANEOUS EMPHYSEMA 19 0.0193
79 GALLBLADDER NECROSIS 3 0.0190
80 ENDOTRACHEAL INTUBATION COMPLICATION 11 0.0186
81 SCROTAL ABSCESS 7 0.0185
82 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 7 0.0184
83 SPINAL EPIDURAL HAEMATOMA 10 0.0170
84 PROCEDURAL VOMITING 11 0.0169
85 HYPERCAPNIA 50 0.0166
86 TENDON OPERATION 8 0.0166
87 PULSELESS ELECTRICAL ACTIVITY 69 0.0165
88 ELECTROCARDIOGRAM P WAVE ABNORMAL 4 0.0163
89 SKIN TEST POSITIVE 15 0.0161
90 SPINAL CORD INFARCTION 7 0.0159
91 PROPOFOL INFUSION SYNDROME 11 0.0156
92 MYOCARDIAL DEPRESSION 4 0.0155
93 GRANULOCYTOSIS 3 0.0153
94 THORACIC CAVITY DRAINAGE 4 0.0150
95 AIR EMBOLISM 7 0.0149
96 ANAPHYLACTIC SHOCK 383 0.0148
97 AMYLASE INCREASED 54 0.0146
98 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 5 0.0144
99 RESPIRATORY ACIDOSIS 55 0.0140
100 OROMANDIBULAR DYSTONIA 10 0.0137
101 IRREGULAR BREATHING 8 0.0136
102 ALLERGY TEST POSITIVE 6 0.0132
103 LUMBAR PUNCTURE 5 0.0132
104 ANAPHYLACTIC REACTION 726 0.0131
105 TRYPTASE INCREASED 9 0.0126
106 PROCEDURAL NAUSEA 10 0.0124
107 CLOSTRIDIAL SEPSIS 3 0.0124
108 GENITAL ABSCESS 5 0.0124
109 BRONCHOSPASM 176 0.0123
110 TOXIC ENCEPHALOPATHY 62 0.0122
111 BRADYCARDIA FOETAL 10 0.0120
112 ANTICHOLINERGIC SYNDROME 19 0.0119
113 VASOPLEGIA SYNDROME 19 0.0116
114 THYROTOXIC CRISIS 13 0.0114
115 TENOSYNOVITIS 31 0.0112
116 OPERATIVE HAEMORRHAGE 5 0.0112
117 STRESS CARDIOMYOPATHY 65 0.0112
118 WEANING FAILURE 4 0.0110
119 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 12 0.0109
120 CEREBRAL HYPOPERFUSION 5 0.0107
121 ANAPHYLACTOID SHOCK 5 0.0106
122 ANISOCORIA 4 0.0106
123 LARYNGEAL STENOSIS 6 0.0104
124 NEURODEVELOPMENTAL DISORDER 7 0.0104
125 FOETAL EXPOSURE DURING DELIVERY 7 0.0103
126 APGAR SCORE LOW 13 0.0101
127 DIAPHRAGMATIC PARALYSIS 6 0.0100
128 VITAMIN K DEFICIENCY 4 0.0100
129 HYPOVENTILATION 32 0.0098
130 INFECTIVE EXACERBATION OF BRONCHIECTASIS 3 0.0098
131 BIOPSY LIVER 4 0.0097
132 PSYCHOGENIC SEIZURE 9 0.0096
133 BRONCHIAL HAEMORRHAGE 3 0.0096
134 ABDOMINAL COMPARTMENT SYNDROME 6 0.0094
135 ANAESTHETIC COMPLICATION 25 0.0093
136 DEFECT CONDUCTION INTRAVENTRICULAR 3 0.0093
137 BREAST CANCER RECURRENT 29 0.0092
138 DRUG EFFECT PROLONGED 5 0.0091
139 MYASTHENIC SYNDROME 7 0.0090
140 UPPER AIRWAY OBSTRUCTION 8 0.0090
141 GRIMACING 7 0.0090
142 SINUS ARREST 14 0.0089
143 LARYNGOSPASM 24 0.0089
144 PERINEAL ABSCESS 4 0.0089
145 OPISTHOTONUS 7 0.0088
146 BRONCHOPULMONARY DYSPLASIA 7 0.0087
147 CIRCUMORAL OEDEMA 3 0.0086
148 NEUROMUSCULAR TOXICITY 3 0.0085
149 HAEMODYNAMIC INSTABILITY 65 0.0085
150 FANCONI SYNDROME 12 0.0085
151 ELECTROCARDIOGRAM ST-T CHANGE 6 0.0085
152 ACIDOSIS HYPERCHLORAEMIC 5 0.0084
153 CLONUS 23 0.0084
154 COAGULATION TIME PROLONGED 13 0.0084
155 DISSOCIATIVE DISORDER 6 0.0083
156 ABSCESS BACTERIAL 3 0.0083
157 NEONATAL HYPOTENSION 3 0.0082
158 EVANS SYNDROME 4 0.0081
159 RESPIRATORY TRACT OEDEMA 6 0.0081
160 SENSORIMOTOR DISORDER 4 0.0080
161 TROPONIN INCREASED 61 0.0080
162 BREAST RECONSTRUCTION 3 0.0080
163 SEROTONIN SYNDROME 153 0.0080
164 HAEMOTHORAX 23 0.0079
165 ELECTROCARDIOGRAM PR PROLONGATION 6 0.0078
166 NEUROBLASTOMA 3 0.0078
167 HYPOPERFUSION 8 0.0076
168 MYOCARDIAL OEDEMA 3 0.0076
169 LYMPHOCELE 5 0.0075
170 DEPENDENCE ON RESPIRATOR 3 0.0075
171 ELECTROCARDIOGRAM T WAVE PEAKED 3 0.0075
172 POSTPARTUM HAEMORRHAGE 10 0.0074
173 PARAPLEGIA 21 0.0073
174 CANDIDA TEST POSITIVE 3 0.0072
175 ANENCEPHALY 4 0.0071
176 PUPIL FIXED 12 0.0069
177 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 18 0.0069
178 OESOPHAGEAL DILATATION 3 0.0068
179 PULMONARY ALVEOLAR HAEMORRHAGE 38 0.0068
180 THERAPEUTIC PRODUCT CROSS-REACTIVITY 6 0.0067
181 RESPIRATORY TRACT HAEMORRHAGE 4 0.0067
182 NON-CARDIOGENIC PULMONARY OEDEMA 7 0.0066
183 FINGER DEFORMITY 32 0.0066
184 HYPERREFLEXIA 23 0.0066
185 CIRCULATORY COLLAPSE 112 0.0066
186 OCULOGYRIC CRISIS 14 0.0065
187 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 21 0.0063
188 GASTROSCHISIS 3 0.0063
189 TYPE I HYPERSENSITIVITY 22 0.0062
190 CYANOSIS NEONATAL 4 0.0062
191 INFANTILE APNOEA 5 0.0061
192 BLINDNESS CORTICAL 3 0.0061
193 DYSCHROMATOPSIA 5 0.0060
194 AMAUROSIS 5 0.0059
195 ADRENAL SUPPRESSION 5 0.0059
196 PRODUCT CONTAMINATION MICROBIAL 7 0.0059
197 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 9 0.0059
198 ELECTROENCEPHALOGRAM ABNORMAL 18 0.0057
199 CARDIAC OUTPUT DECREASED 5 0.0057
200 NEONATAL ASPHYXIA 4 0.0056
201 PCO2 INCREASED 4 0.0056
202 BRONCHOSTENOSIS 3 0.0055
203 ARTERIOSPASM CORONARY 22 0.0055
204 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 12 0.0055
205 RIGHT VENTRICULAR DYSFUNCTION 6 0.0054
206 PROCEDURAL HAEMORRHAGE 21 0.0054
207 ACIDOSIS 41 0.0054
208 MYOCARDIAL INJURY 6 0.0053
209 APNOEA 41 0.0053
210 COAGULATION TEST ABNORMAL 4 0.0052
211 MUCOSAL HAEMORRHAGE 6 0.0052
212 ADRENOCORTICAL INSUFFICIENCY ACUTE 10 0.0051
213 DOSE CALCULATION ERROR 3 0.0051
214 PRINZMETAL ANGINA 5 0.0050
215 HAEMOPERITONEUM 4 0.0050
216 HEPATITIS VIRAL 4 0.0050
217 PRODUCT MEASURED POTENCY ISSUE 5 0.0050
218 VENTRICULAR FIBRILLATION 55 0.0049
219 RESPIRATORY DEPRESSION 60 0.0049
220 HYPOXIA 171 0.0049
221 RESUSCITATION 8 0.0048
222 FOETAL HEART RATE DECREASED 3 0.0048
223 LIMB OPERATION 23 0.0048
224 COGWHEEL RIGIDITY 5 0.0048
225 BLOOD PH DECREASED 8 0.0047
226 ENDOTRACHEAL INTUBATION 13 0.0046
227 ENDOCRINE OPHTHALMOPATHY 4 0.0046
228 HYPERMAGNESAEMIA 3 0.0046
229 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
230 PERIRECTAL ABSCESS 5 0.0045
231 HYPOVOLAEMIA 26 0.0044
232 RIGHT VENTRICULAR HYPERTROPHY 4 0.0044
233 TYPE IV HYPERSENSITIVITY REACTION 12 0.0044
234 RASH MORBILLIFORM 12 0.0043
235 SEDATION COMPLICATION 11 0.0043
236 LUNG CONSOLIDATION 12 0.0043
237 ATRIOVENTRICULAR BLOCK SECOND DEGREE 13 0.0043
238 MAST CELL ACTIVATION SYNDROME 6 0.0043
239 BRONCHIAL OBSTRUCTION 6 0.0043
240 RESTRICTIVE PULMONARY DISEASE 5 0.0043
241 BRADYARRHYTHMIA 7 0.0043
242 SHOCK HAEMORRHAGIC 34 0.0042
243 CONVERSION DISORDER 8 0.0041
244 GAZE PALSY 7 0.0041
245 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 21 0.0041
246 DRUG-DISEASE INTERACTION 3 0.0041
247 TORSADE DE POINTES 32 0.0041
248 CHOREA 7 0.0041
249 HEART INJURY 10 0.0040
250 CARDIAC ARREST 331 0.0040
251 BRAIN STEM SYNDROME 3 0.0040
252 DEVICE RELATED SEPSIS 8 0.0040
253 ANGIOPATHY 22 0.0039
254 INCREASED BRONCHIAL SECRETION 10 0.0039
255 BRADYCARDIA 207 0.0039
256 CONJUNCTIVAL OEDEMA 4 0.0039
257 ATRIOVENTRICULAR BLOCK COMPLETE 26 0.0039
258 SLOW RESPONSE TO STIMULI 5 0.0039
259 METAPNEUMOVIRUS INFECTION 3 0.0038
260 VENTRICULAR ARRHYTHMIA 14 0.0038
261 INHIBITORY DRUG INTERACTION 6 0.0038
262 BLOOD LACTATE DEHYDROGENASE INCREASED 60 0.0038
263 STRIDOR 11 0.0037
264 CEREBRAL ARTERY OCCLUSION 4 0.0037
265 HYPERLACTACIDAEMIA 10 0.0037
266 RESPIRATORY ALKALOSIS 6 0.0037
267 BREAST OPERATION 3 0.0037
268 DYSBIOSIS 3 0.0037
269 LOW BIRTH WEIGHT BABY 29 0.0036
270 BLOOD POTASSIUM INCREASED 59 0.0036
271 VENTRICULAR TACHYCARDIA 60 0.0036
272 PERITONEAL HAEMORRHAGE 5 0.0036
273 VOCAL CORD DISORDER 7 0.0035
274 ATELECTASIS 34 0.0035
275 CEREBELLAR HAEMORRHAGE 5 0.0035
276 PRIAPISM 12 0.0035
277 COVID-19 PNEUMONIA 41 0.0035
278 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
279 HYPOPNOEA 12 0.0035
280 VASCULAR STENT THROMBOSIS 7 0.0034
281 THERAPEUTIC PRODUCT EFFECT INCREASED 4 0.0034
282 NODAL RHYTHM 5 0.0034
283 FOOD INTERACTION 6 0.0034
284 PULSE ABSENT 16 0.0034
285 PREMATURE DELIVERY 53 0.0033
286 PNEUMOMEDIASTINUM 6 0.0033
287 PNEUMOPERITONEUM 6 0.0032
288 MULTIPLE ORGAN DYSFUNCTION SYNDROME 92 0.0032
289 LARYNGEAL OEDEMA 20 0.0032
290 LANGUAGE DISORDER 7 0.0032
291 ADENOCARCINOMA GASTRIC 3 0.0032
292 PNEUMOTHORAX 51 0.0032
293 HYPOTENSION 643 0.0032
294 CATHETER SITE HAEMORRHAGE 8 0.0032
295 PREMATURE BABY 96 0.0032
296 HYPERAESTHESIA TEETH 4 0.0032
297 BRONCHIAL SECRETION RETENTION 4 0.0031
298 MUSCLE RIGIDITY 37 0.0031
299 COMPLICATIONS OF TRANSPLANTED KIDNEY 7 0.0031
300 DRUG LEVEL BELOW THERAPEUTIC 17 0.0031
301 EXTRADURAL HAEMATOMA 4 0.0030
302 METHAEMOGLOBINAEMIA 7 0.0030
303 PROCEDURAL COMPLICATION 23 0.0030
304 PARADOXICAL DRUG REACTION 11 0.0030
305 BRAIN HYPOXIA 3 0.0030
306 ATRIOVENTRICULAR BLOCK 23 0.0030
307 GENERALISED TONIC-CLONIC SEIZURE 49 0.0030
308 CARBON DIOXIDE INCREASED 4 0.0029
309 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28 0.0029
310 ISCHAEMIC HEPATITIS 4 0.0029
311 TACHYPNOEA 39 0.0029
312 BRASH SYNDROME 4 0.0028
313 STAPHYLOCOCCUS TEST POSITIVE 6 0.0028
314 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
315 ASTERIXIS 3 0.0028
316 VENTRICULAR HYPOKINESIA 9 0.0028
317 HEART VALVE INCOMPETENCE 8 0.0028
318 VOCAL CORD PARALYSIS 5 0.0028
319 HEPATITIS ACUTE 18 0.0028
320 HYPOTHERMIA 28 0.0028
321 STATUS EPILEPTICUS 31 0.0027
322 DYSTONIA 53 0.0027
323 CARDIOGENIC SHOCK 39 0.0027
324 CARDIAC DYSFUNCTION 10 0.0027
325 EMPHYSEMA 27 0.0027
326 SHOCK 61 0.0026
327 HYPERSENSITIVITY PNEUMONITIS 3 0.0026
328 AREFLEXIA 7 0.0026
329 HYPERNATRAEMIA 13 0.0026
330 NEPHROGENIC DIABETES INSIPIDUS 3 0.0026
331 BRADYPNOEA 7 0.0026
332 HAEMOLYTIC URAEMIC SYNDROME 6 0.0026
333 TRAUMATIC LUNG INJURY 5 0.0026
334 HYDROCEPHALUS 14 0.0026
335 MUSCLE CONTRACTIONS INVOLUNTARY 9 0.0026
336 GROIN ABSCESS 3 0.0025
337 UNDERWEIGHT 5 0.0025
338 NEUROLEPTIC MALIGNANT SYNDROME 30 0.0025
339 PATENT DUCTUS ARTERIOSUS 10 0.0025
340 TACHYCARDIA 223 0.0025
341 LONG QT SYNDROME 6 0.0025
342 HYPERKALAEMIA 87 0.0025
343 RETROPERITONEAL HAEMORRHAGE 6 0.0024
344 ANAPHYLACTOID REACTION 10 0.0024
345 HYPERVOLAEMIA 12 0.0024
346 QUADRIPARESIS 4 0.0024
347 TROPONIN I INCREASED 4 0.0024
348 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
349 VASODILATATION 6 0.0024
350 SINUS BRADYCARDIA 23 0.0024
351 HYPERTHERMIA 18 0.0024
352 FOETAL DISTRESS SYNDROME 5 0.0024
353 PARALYSIS 33 0.0023
354 MONOPLEGIA 10 0.0023
355 OXYGEN SATURATION DECREASED 129 0.0023
356 BLOOD CREATINE PHOSPHOKINASE INCREASED 66 0.0023
357 ACUTE RESPIRATORY FAILURE 44 0.0023
358 FANCONI SYNDROME ACQUIRED 4 0.0023
359 GASTROENTERITIS NOROVIRUS 3 0.0023
360 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
361 DISTRIBUTIVE SHOCK 5 0.0022
362 FACE OEDEMA 37 0.0022
363 CONDUCTION DISORDER 4 0.0022
364 HEAD TITUBATION 3 0.0022
365 RESPIRATORY ARREST 60 0.0022
366 INCISIONAL HERNIA 3 0.0022
367 BLOOD ALBUMIN DECREASED 17 0.0021
368 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
369 TRISMUS 11 0.0021
370 INTENSIVE CARE 3 0.0021
371 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
372 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
373 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
374 SPINAL CORD COMPRESSION 8 0.0021
375 METABOLIC ACIDOSIS 65 0.0020
376 HYPERAEMIA 4 0.0020
377 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 12 0.0020
378 NORMAL NEWBORN 11 0.0020
379 GASTRITIS HAEMORRHAGIC 3 0.0020
380 HYPOTONIA 20 0.0020
381 HYPERPARATHYROIDISM SECONDARY 5 0.0020
382 NECROTISING FASCIITIS 7 0.0020
383 CORONARY ARTERY THROMBOSIS 4 0.0020
384 BRAIN OEDEMA 25 0.0020
385 ACUTE RESPIRATORY DISTRESS SYNDROME 35 0.0020
386 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
387 NEONATAL RESPIRATORY DISTRESS SYNDROME 7 0.0020
388 HYPERTENSIVE CRISIS 22 0.0020
389 RESPIRATORY FAILURE 144 0.0020
390 DRUG INTERACTION 310 0.0020
391 EXTRAVASATION 8 0.0019
392 HYPOTONIA NEONATAL 3 0.0019
393 LIVEDO RETICULARIS 4 0.0019
394 NYSTAGMUS 10 0.0019
395 METABOLIC ALKALOSIS 3 0.0019
396 MYOCARDIAL ISCHAEMIA 21 0.0018
397 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
398 ACUTE HEPATIC FAILURE 25 0.0018
399 PARESIS 4 0.0018
400 CONTRAINDICATED PRODUCT ADMINISTERED 54 0.0018
401 WRONG PRODUCT ADMINISTERED 12 0.0018
402 WOUND DEHISCENCE 6 0.0018
403 BLOOD LOSS ANAEMIA 4 0.0018
404 PULMONARY OEDEMA 79 0.0018
405 ANGIOEDEMA 78 0.0018
406 COAGULOPATHY 29 0.0017
407 ADVERSE REACTION 23 0.0017
408 KIDNEY FIBROSIS 3 0.0017
409 NEUROLOGICAL DECOMPENSATION 4 0.0017
410 NEPHROGENIC ANAEMIA 8 0.0017
411 BLOOD LACTIC ACID INCREASED 9 0.0017
412 BRAIN HERNIATION 5 0.0017
413 GUILLAIN-BARRE SYNDROME 8 0.0017
414 PRODUCT PACKAGING CONFUSION 4 0.0016
415 ESSENTIAL HYPERTENSION 3 0.0016
416 INTRACARDIAC THROMBUS 5 0.0016
417 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
418 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
419 FOETAL EXPOSURE DURING PREGNANCY 130 0.0016
420 RESPIRATORY RATE DECREASED 5 0.0016
421 MECHANICAL VENTILATION 3 0.0016
422 HYPERTONIA 9 0.0016
423 RIGHT VENTRICULAR FAILURE 11 0.0016
424 UNRESPONSIVE TO STIMULI 40 0.0015
425 PORTAL VEIN THROMBOSIS 5 0.0015
426 HEPATITIS TOXIC 4 0.0015
427 COMPARTMENT SYNDROME 4 0.0015
428 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
429 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
430 BODY TEMPERATURE INCREASED 31 0.0015
431 LUNG OPACITY 4 0.0015
432 ANURIA 13 0.0015
433 DERMATITIS ALLERGIC 19 0.0015
434 MYOCLONUS 18 0.0015
435 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
436 LEFT VENTRICULAR DYSFUNCTION 10 0.0015
437 URINE OUTPUT DECREASED 13 0.0015
438 EAR HAEMORRHAGE 3 0.0015
439 MYDRIASIS 19 0.0015
440 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
441 SINUS TACHYCARDIA 21 0.0015
442 SUBSTANCE ABUSE 12 0.0015
443 HYPOVOLAEMIC SHOCK 7 0.0015
444 LEFT VENTRICULAR FAILURE 5 0.0015
445 STILLBIRTH 7 0.0014
446 ELECTROCARDIOGRAM QT PROLONGED 52 0.0014
447 DILATATION VENTRICULAR 3 0.0014
448 OPTIC NEUROPATHY 3 0.0014
449 RESPIRATORY DISTRESS 39 0.0014
450 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 36 0.0014
451 PALLOR 38 0.0014
452 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
453 DYSPHEMIA 6 0.0014
454 LUNG INFILTRATION 12 0.0014
455 ALANINE AMINOTRANSFERASE INCREASED 83 0.0014
456 MIXED LIVER INJURY 4 0.0013
457 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
458 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
459 EYELID DISORDER 3 0.0013
460 ANAL ABSCESS 7 0.0013
461 BRAIN INJURY 13 0.0013
462 DIASTOLIC DYSFUNCTION 4 0.0013
463 RHABDOMYOLYSIS 54 0.0013
464 BRAIN DEATH 4 0.0013
465 OLIGURIA 8 0.0013
466 POST PROCEDURAL HAEMORRHAGE 15 0.0013
467 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
468 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 13 0.0013
469 INTRACRANIAL PRESSURE INCREASED 7 0.0013
470 EXPOSURE DURING PREGNANCY 78 0.0013
471 AZOTAEMIA 5 0.0013
472 VENTRICULAR EXTRASYSTOLES 13 0.0013
473 ACUTE PULMONARY OEDEMA 7 0.0012
474 LOOSE TOOTH 4 0.0012
475 HEMIPARESIS 21 0.0012
476 RESPIRATORY RATE INCREASED 11 0.0012
477 CHOLECYSTITIS ACUTE 7 0.0012
478 BRONCHITIS CHRONIC 3 0.0012
479 RENAL TUBULAR NECROSIS 12 0.0012
480 SEPTIC SHOCK 53 0.0012
481 HYPERAESTHESIA 10 0.0012
482 DEAFNESS NEUROSENSORY 4 0.0012
483 MUSCLE TWITCHING 28 0.0012
484 MUCOUS STOOLS 6 0.0012
485 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
486 ACUTE CORONARY SYNDROME 10 0.0012
487 DYSKINESIA 49 0.0012
488 POST PROCEDURAL COMPLICATION 23 0.0012
489 HYPERPYREXIA 5 0.0012
490 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
491 RESPIRATION ABNORMAL 8 0.0012
492 BLOOD PRESSURE DECREASED 77 0.0012
493 PULMONARY HAEMORRHAGE 9 0.0011
494 DERMATITIS ACNEIFORM 7 0.0011
495 MITRAL VALVE INCOMPETENCE 13 0.0011
496 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
497 LUNG TRANSPLANT 4 0.0011
498 CARDIO-RESPIRATORY ARREST 47 0.0011
499 DELIRIUM 39 0.0011
500 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
501 BLOOD SODIUM INCREASED 3 0.0011
502 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
503 LEUKOCYTOSIS 20 0.0011
504 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
505 POLYURIA 9 0.0011
506 PNEUMONIA BACTERIAL 10 0.0011
507 CYANOSIS 17 0.0011
508 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
509 HYPERBILIRUBINAEMIA 11 0.0011
510 PREMATURE LABOUR 6 0.0011
511 OXYGEN SATURATION ABNORMAL 3 0.0011
512 CARDIAC FAILURE ACUTE 7 0.0010
513 GENERALISED OEDEMA 13 0.0010
514 MULTI-ORGAN FAILURE 18 0.0010
515 OESOPHAGEAL DISORDER 4 0.0010
516 COMA SCALE ABNORMAL 3 0.0010
517 TRANSAMINASES INCREASED 23 0.0010
518 RALES 6 0.0010
519 COMA 49 0.0010
520 MATERNAL EXPOSURE DURING PREGNANCY 89 0.0010
521 MIOSIS 8 0.0010
522 EMBOLISM VENOUS 3 0.0010
523 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
524 EUGLYCAEMIC DIABETIC KETOACIDOSIS 4 0.0010
525 ELECTROLYTE IMBALANCE 11 0.0009
526 SCREAMING 6 0.0009
527 ABSCESS LIMB 4 0.0009
528 THROMBOTIC MICROANGIOPATHY 9 0.0009
529 PLEURAL EFFUSION 56 0.0009
530 TENDON DISORDER 6 0.0009
531 ASPIRATION 10 0.0009
532 JAW DISORDER 5 0.0009
533 NEAR DEATH EXPERIENCE 3 0.0009
534 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
535 DRUG LEVEL INCREASED 15 0.0009
536 PHYSICAL DISABILITY 4 0.0009
537 OLIGOHYDRAMNIOS 3 0.0009
538 RASH MACULO-PAPULAR 20 0.0009
539 IRON DEFICIENCY 4 0.0009
540 HAEMATOMA 23 0.0009
541 MOTOR DYSFUNCTION 9 0.0009
542 CARDIOMYOPATHY 13 0.0009
543 RENAL FAILURE ACUTE 37 0.0009
544 CAESAREAN SECTION 10 0.0009
545 URTICARIA 143 0.0009
546 LOGORRHOEA 3 0.0009
547 CHOLECYSTITIS 10 0.0008
548 DEVICE PLACEMENT ISSUE 3 0.0008
549 LIVE BIRTH 7 0.0008
550 ACUTE KIDNEY INJURY 128 0.0008
551 LACTIC ACIDOSIS 27 0.0008
552 KIDNEY TRANSPLANT REJECTION 4 0.0008
553 FAECAL INCONTINENCE 4 0.0008
554 RASH VESICULAR 4 0.0008
555 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
556 KETOACIDOSIS 6 0.0008
557 HEPATIC NECROSIS 3 0.0008
558 SUBARACHNOID HAEMORRHAGE 8 0.0008
559 PERIPHERAL VASCULAR DISORDER 4 0.0008
560 PERIORBITAL OEDEMA 4 0.0008
561 PULMONARY CONGESTION 10 0.0008
562 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
563 SEPSIS 84 0.0008
564 ATRIAL FLUTTER 6 0.0008
565 NEPHROPATHY 7 0.0007
566 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
567 ANAL FISSURE 4 0.0007
568 SENSORY LOSS 6 0.0007
569 PRODUCT ADMINISTRATION ERROR 15 0.0007
570 NEUROTOXICITY 13 0.0007
571 ADRENAL INSUFFICIENCY 9 0.0007
572 POSTOPERATIVE WOUND INFECTION 5 0.0007
573 DRUG RESISTANCE 19 0.0007
574 ECCHYMOSIS 5 0.0007
575 MENTAL STATUS CHANGES 20 0.0007
576 NECROSIS 4 0.0007
577 HEART RATE ABNORMAL 4 0.0007
578 HAEMOPTYSIS 20 0.0007
579 ACUTE MYOCARDIAL INFARCTION 21 0.0007
580 CHROMATURIA 16 0.0007
581 AGITATION 52 0.0007
582 BUNDLE BRANCH BLOCK LEFT 3 0.0007
583 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
584 DRUG-INDUCED LIVER INJURY 22 0.0007
585 HIATUS HERNIA 9 0.0007
586 ENCEPHALOPATHY 17 0.0007
587 PRODUCT LABEL CONFUSION 4 0.0007
588 HYPERTRIGLYCERIDAEMIA 4 0.0007
589 MOUTH HAEMORRHAGE 5 0.0007
590 PNEUMONIA ASPIRATION 17 0.0007
591 BLOOD CREATINE INCREASED 3 0.0007
592 BACTERAEMIA 8 0.0007
593 CARDIOTOXICITY 6 0.0007
594 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
595 DRUG EFFECT DELAYED 3 0.0007
596 ISCHAEMIA 3 0.0007
597 UROSEPSIS 6 0.0006
598 LOCALISED OEDEMA 3 0.0006
599 HAEMOLYSIS 5 0.0006
600 RENAL INJURY 19 0.0006
601 DERMATITIS CONTACT 7 0.0006
602 PHARYNGEAL SWELLING 6 0.0006
603 BREATH SOUNDS ABNORMAL 3 0.0006
604 LIVER FUNCTION TEST INCREASED 13 0.0006
605 INFLAMMATORY MARKER INCREASED 3 0.0006
606 HAEMORRHAGE 63 0.0006
607 FLUID INTAKE REDUCED 3 0.0006
608 TOXICITY TO VARIOUS AGENTS 101 0.0006
609 HEART RATE DECREASED 21 0.0006
610 ARTHROPATHY 33 0.0006
611 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
612 HAEMATEMESIS 15 0.0006
613 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
614 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
615 FOETAL DEATH 3 0.0006
616 HYPERGLYCAEMIA 21 0.0006
617 APLASTIC ANAEMIA 3 0.0006
618 NO THERAPEUTIC RESPONSE 7 0.0006
619 EXTRASYSTOLES 4 0.0006
620 CATATONIA 3 0.0006
621 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
622 ABSCESS 9 0.0006
623 JAUNDICE 15 0.0006
624 THERAPY NON-RESPONDER 25 0.0006
625 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
626 RESTLESSNESS 20 0.0005
627 RENAL FAILURE 72 0.0005
628 CYSTIC FIBROSIS 3 0.0005
629 HYPOPHOSPHATAEMIA 4 0.0005
630 BLOOD UREA INCREASED 9 0.0005
631 RENAL IMPAIRMENT 45 0.0005
632 INTESTINAL PERFORATION 6 0.0005
633 CEREBRAL INFARCTION 13 0.0005
634 PULMONARY HYPERTENSION 11 0.0005
635 RECALLED PRODUCT ADMINISTERED 5 0.0005
636 EJECTION FRACTION DECREASED 8 0.0005
637 THERAPY CHANGE 5 0.0005
638 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
639 TREATMENT FAILURE 42 0.0005
640 RENAL CYST 4 0.0005
641 TRICUSPID VALVE INCOMPETENCE 4 0.0005
642 RESPIRATORY DISORDER 15 0.0005
643 CYTOKINE RELEASE SYNDROME 10 0.0005
644 HYPOKALAEMIA 23 0.0005
645 INGUINAL HERNIA 3 0.0005
646 MUSCLE SPASTICITY 6 0.0005
647 CARDIOMEGALY 6 0.0005
648 HYPERCALCAEMIA 6 0.0005
649 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
650 FEAR 13 0.0005
651 EXTRAPYRAMIDAL DISORDER 12 0.0005
652 INFUSION SITE EXTRAVASATION 3 0.0005
653 EPISTAXIS 36 0.0005
654 FLUID OVERLOAD 7 0.0005
655 HAEMODIALYSIS 4 0.0005
656 DRUG USE DISORDER 4 0.0005
657 CANDIDA INFECTION 8 0.0005
658 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
659 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
660 HYPERSENSITIVITY 87 0.0005
661 ECONOMIC PROBLEM 7 0.0005
662 PYELONEPHRITIS 4 0.0005
663 FAECES DISCOLOURED 10 0.0005
664 HYPERTENSION 97 0.0005
665 WHEEZING 27 0.0005
666 DEVICE RELATED INFECTION 7 0.0005
667 WRONG DRUG ADMINISTERED 4 0.0004
668 CHOLECYSTITIS CHRONIC 3 0.0004
669 MYOSITIS 4 0.0004
670 NEPHROPATHY TOXIC 5 0.0004
671 REBOUND EFFECT 5 0.0004
672 ATRIAL FIBRILLATION 43 0.0004
673 FLATULENCE 25 0.0004
674 EYE MOVEMENT DISORDER 3 0.0004
675 MYOCARDITIS 5 0.0004
676 LARGE INTESTINE PERFORATION 3 0.0004
677 BLOOD CREATININE INCREASED 28 0.0004
678 HEPATIC ENCEPHALOPATHY 4 0.0004
679 SKIN REACTION 6 0.0004
680 RASH GENERALISED 11 0.0004
681 STAPHYLOCOCCAL INFECTION 14 0.0004
682 SEIZURE 49 0.0004
683 SLEEP APNOEA SYNDROME 8 0.0004
684 ANHEDONIA 11 0.0004
685 RASH ERYTHEMATOUS 20 0.0004
686 GRAFT VERSUS HOST DISEASE 3 0.0004
687 DERMATITIS BULLOUS 3 0.0004
688 DRUG EFFECT DECREASED 22 0.0004
689 HEPATOMEGALY 4 0.0004
690 BLINDNESS TRANSIENT 3 0.0004
691 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
692 ERYTHEMA 83 0.0004
693 HEPATIC FUNCTION ABNORMAL 15 0.0004
694 HAEMORRHAGE INTRACRANIAL 6 0.0004
695 ARRHYTHMIA 19 0.0004
696 HEPATIC FAILURE 12 0.0004
697 LIPASE INCREASED 3 0.0004
698 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
699 CEREBRAL HAEMORRHAGE 14 0.0004
700 PULMONARY EMBOLISM 37 0.0004
701 RASH PRURITIC 21 0.0004
702 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
703 BONE DISORDER 7 0.0004
704 INJURY 27 0.0004
705 END STAGE RENAL DISEASE 7 0.0004
706 FLUSHING 39 0.0004
707 WITHDRAWAL SYNDROME 16 0.0004
708 DISORIENTATION 15 0.0004
709 ASCITES 11 0.0004
710 HEART RATE INCREASED 37 0.0004
711 DYSARTHRIA 14 0.0004
712 MYASTHENIA GRAVIS 3 0.0004
713 MUSCLE DISORDER 3 0.0004
714 BLOOD BILIRUBIN INCREASED 10 0.0004
715 DRUG INEFFECTIVE 487 0.0004
716 CONDITION AGGRAVATED 112 0.0004
717 DECUBITUS ULCER 3 0.0004
718 HICCUPS 3 0.0004
719 EMBOLISM 3 0.0004
720 URINARY RETENTION 12 0.0004
721 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
722 MALNUTRITION 4 0.0004
723 ACCIDENTAL OVERDOSE 13 0.0004
724 PRODUCT USE IN UNAPPROVED INDICATION 88 0.0004
725 DISABILITY 7 0.0004
726 SWOLLEN TONGUE 11 0.0004
727 MYOPATHY 3 0.0003
728 CARDIAC MURMUR 3 0.0003
729 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
730 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
731 EYELID OEDEMA 4 0.0003
732 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
733 OVERDOSE 73 0.0003
734 ATAXIA 4 0.0003
735 HYPERLIPIDAEMIA 4 0.0003
736 BLOOD PRESSURE FLUCTUATION 8 0.0003
737 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
738 GRAND MAL CONVULSION 3 0.0003
739 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
740 SWELLING FACE 21 0.0003
741 BACTERIAL INFECTION 6 0.0003
742 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
743 DRUG WITHDRAWAL SYNDROME 28 0.0003
744 OFF LABEL USE 275 0.0003
745 OBESITY 5 0.0003
746 LIVER FUNCTION TEST ABNORMAL 9 0.0003
747 MUCOSAL INFLAMMATION 8 0.0003
748 BLOOD POTASSIUM DECREASED 9 0.0003
749 PERIPHERAL SWELLING 46 0.0003
750 RASH 129 0.0003
751 EYELID PTOSIS 3 0.0003
752 DYSPHAGIA 28 0.0003
753 HYPERHIDROSIS 38 0.0003
754 IMPAIRED GASTRIC EMPTYING 4 0.0003
755 BLOOD PRESSURE INCREASED 44 0.0003
756 HYPOMAGNESAEMIA 4 0.0003
757 LIVER INJURY 7 0.0003
758 JOINT DISLOCATION 3 0.0003
759 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
760 PAIN IN JAW 8 0.0003
761 DIALYSIS 4 0.0003
762 RETCHING 6 0.0003
763 EMOTIONAL DISTRESS 34 0.0003
764 CHRONIC KIDNEY DISEASE 21 0.0003
765 HYPERTHYROIDISM 4 0.0003
766 CARDIOVASCULAR DISORDER 7 0.0003
767 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
768 DYSPHONIA 16 0.0003
769 LOSS OF CONSCIOUSNESS 35 0.0003
770 MELAENA 6 0.0003
771 DRUG WITHDRAWAL SYNDROME NEONATAL 4 0.0003
772 DIPLOPIA 7 0.0003
773 HEPATOTOXICITY 6 0.0003
774 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
775 CARDIAC FAILURE 21 0.0003
776 LETHARGY 15 0.0003
777 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
778 PARAESTHESIA 40 0.0003
779 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
780 PROCEDURAL PAIN 7 0.0003
781 HAEMATOCRIT DECREASED 5 0.0003
782 MEDICATION ERROR 14 0.0003
783 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
784 HYPOTHYROIDISM 8 0.0003
785 THROMBOCYTOPENIA 28 0.0003
786 SENSORY DISTURBANCE 4 0.0002
787 DEEP VEIN THROMBOSIS 16 0.0002
788 ILEUS 3 0.0002
789 OEDEMA 13 0.0002
790 TINNITUS 11 0.0002
791 HALLUCINATION, VISUAL 5 0.0002
792 MUSCLE ATROPHY 3 0.0002
793 HEPATIC ENZYME INCREASED 16 0.0002
794 HYPOPHAGIA 6 0.0002
795 HAEMATURIA 8 0.0002
796 APHASIA 7 0.0002
797 PNEUMONIA 75 0.0002
798 SEDATION 6 0.0002
799 AMENORRHOEA 4 0.0002
800 LIVER DISORDER 10 0.0002
801 LUNG DISORDER 11 0.0002
802 HAEMOGLOBIN DECREASED 23 0.0002
803 MUSCULAR WEAKNESS 25 0.0002
804 C-REACTIVE PROTEIN INCREASED 8 0.0002
805 CELLULITIS 11 0.0002
806 INTENTIONAL OVERDOSE 14 0.0002
807 BLOOD GLUCOSE ABNORMAL 4 0.0002
808 PERICARDIAL EFFUSION 5 0.0002
809 HEPATIC STEATOSIS 4 0.0002
810 SUICIDE ATTEMPT 13 0.0002
811 UNEVALUABLE EVENT 16 0.0002
812 CONFUSIONAL STATE 34 0.0002
813 LIP SWELLING 7 0.0002
814 ANGINA PECTORIS 6 0.0002
815 IMPAIRED QUALITY OF LIFE 3 0.0002
816 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
817 PRESCRIBED OVERDOSE 4 0.0002
818 HYPOKINESIA 3 0.0002
819 PRODUCT QUALITY ISSUE 28 0.0002
820 GASTROENTERITIS 3 0.0002
821 URINARY INCONTINENCE 6 0.0002
822 FEEDING DISORDER 4 0.0002
823 DEVICE FAILURE 3 0.0002
824 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
825 RIB FRACTURE 4 0.0002
826 INTENTIONAL PRODUCT MISUSE 17 0.0002
827 ANKLE FRACTURE 3 0.0002
828 DRUG EFFECT INCOMPLETE 7 0.0002
829 NERVOUS SYSTEM DISORDER 6 0.0002
830 HYPOGLYCAEMIA 9 0.0002
831 DYSPNOEA 104 0.0002
832 PRODUCT PRESCRIBING ISSUE 4 0.0002
833 METASTASES TO BONE 3 0.0002
834 NO ADVERSE EVENT 33 0.0002
835 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
836 AGGRESSION 9 0.0002
837 CHILLS 21 0.0002
838 MYOCARDIAL INFARCTION 31 0.0002
839 SOMNOLENCE 35 0.0002
840 LOCAL SWELLING 3 0.0002
841 EOSINOPHILIA 3 0.0002
842 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
843 COMPLETED SUICIDE 14 0.0002
844 FEBRILE NEUTROPENIA 11 0.0002
845 OSTEOMYELITIS 3 0.0002
846 HAEMATOCHEZIA 9 0.0002
847 DYSURIA 6 0.0002
848 DRUG ADMINISTRATION ERROR 5 0.0002
849 AGRANULOCYTOSIS 3 0.0002
850 HYPONATRAEMIA 9 0.0002
851 PRODUCT USE ISSUE 30 0.0002
852 DYSPNOEA EXERTIONAL 6 0.0002
853 BACK PAIN 37 0.0002
854 PYREXIA 55 0.0002
855 GLAUCOMA 3 0.0002
856 NIGHT SWEATS 5 0.0002
857 SKIN ULCER 4 0.0002
858 NEPHROLITHIASIS 7 0.0002
859 CHOLELITHIASIS 5 0.0002
860 IMPAIRED HEALING 5 0.0002
861 ANAEMIA 29 0.0002
862 PLATELET COUNT DECREASED 16 0.0001
863 DISCOMFORT 9 0.0001
864 VOMITING 67 0.0001
865 RECTAL HAEMORRHAGE 6 0.0001
866 PRODUCT SUBSTITUTION ISSUE 8 0.0001
867 SWELLING 13 0.0001
868 MENTAL DISORDER 6 0.0001
869 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
870 ANXIETY 39 0.0001
871 THROMBOSIS 11 0.0001
872 INFLAMMATION 7 0.0001
873 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
874 EPILEPSY 4 0.0001
875 SKIN DISCOLOURATION 6 0.0001
876 FEELING HOT 8 0.0001
877 COGNITIVE DISORDER 6 0.0001
878 HEAD INJURY 4 0.0001
879 PANCYTOPENIA 7 0.0001
880 MOVEMENT DISORDER 4 0.0001
881 MENTAL IMPAIRMENT 3 0.0001
882 COUGH 34 0.0001
883 OSTEONECROSIS OF JAW 3 0.0001
884 HYPOAESTHESIA 18 0.0001
885 VIRAL INFECTION 4 0.0001
886 LEUKOPENIA 6 0.0001
887 SYNCOPE 12 0.0001
888 HALLUCINATION 9 0.0001
889 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
890 OSTEOARTHRITIS 5 0.0001
891 MYALGIA 20 0.0001
892 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
893 HEPATITIS 3 0.0001
894 NEUROPATHY PERIPHERAL 11 0.0001
895 DEAFNESS 3 0.0001
896 CONSTIPATION 25 0.0001
897 PANCREATITIS 6 0.0001
898 CARDIAC FAILURE CONGESTIVE 9 0.0001
899 URINARY TRACT INFECTION 19 0.0001
900 CRYING 4 0.0001
901 PAIN 67 0.0001
902 DRUG ABUSE 9 0.0001
903 OROPHARYNGEAL PAIN 10 0.0001
904 RENAL DISORDER 5 0.0001
905 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
906 ABDOMINAL DISTENSION 11 0.0001
907 CONVULSION 6 0.0001
908 MUSCLE SPASMS 19 0.0001
909 DYSSTASIA 3 0.0001
910 MUSCULOSKELETAL STIFFNESS 9 0.0001
911 COVID-19 18 0.0001
912 CHEST PAIN 19 0.0001
913 SURGERY 6 0.0001
914 THERAPEUTIC RESPONSE DECREASED 6 0.0001
915 EXTRA DOSE ADMINISTERED 4 0.0001
916 DRY MOUTH 8 0.0001
917 ASTHENIA 37 0.0001
918 BLINDNESS 4 0.0001
919 OSTEOPOROSIS 4 0.0001
920 FEMUR FRACTURE 3 0.0001
921 TREMOR 16 0.0001
922 OEDEMA PERIPHERAL 11 0.0001
923 GAIT INABILITY 3 0.0001
924 GASTROINTESTINAL DISORDER 8 0.0001
925 BLISTER 5 0.0001
926 CEREBROVASCULAR ACCIDENT 15 0.0001
927 INCORRECT DOSE ADMINISTERED 20 0.0001
928 LYMPHADENOPATHY 3 0.0001
929 DISEASE PROGRESSION 10 0.0001
930 OCULAR HYPERAEMIA 4 0.0001
931 NAUSEA 66 0.0001
932 IRRITABILITY 5 0.0001
933 VISION BLURRED 11 0.0001
934 INTESTINAL OBSTRUCTION 3 0.0001
935 COLITIS 3 0.0001
936 DEPRESSION 18 0.0001
937 CHEST DISCOMFORT 8 0.0001
938 FALL 26 0.0001
939 THERAPY CESSATION 4 0.0001
940 AMNESIA 5 0.0001
941 MUSCULOSKELETAL PAIN 4 0.0001
942 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
943 DISTURBANCE IN ATTENTION 4 0.0001
944 TREATMENT NONCOMPLIANCE 4 0.0001
945 MEMORY IMPAIRMENT 10 0.0001
946 DEATH 62 0.0001
947 NECK PAIN 4 0.0001
948 MALAISE 31 0.0001
949 DEVICE LEAKAGE 3 0.0001
950 DEVICE DISLOCATION 3 0.0001
951 BONE PAIN 4 0.0001
952 NEUTROPENIA 9 0.0001
953 ILL-DEFINED DISORDER 4 0.0001
954 MULTIPLE SCLEROSIS 3 0.0001
955 INTERSTITIAL LUNG DISEASE 3 0.0001
956 INFUSION RELATED REACTION 4 0.0001
957 ABDOMINAL PAIN 14 0.0001
958 FLUID RETENTION 3 0.0001
959 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
960 ECZEMA 3 0.0001
961 PRODUCT STORAGE ERROR 5 0.0001
962 DIARRHOEA 36 0.0001
963 INFECTION 8 0.0001
964 DIZZINESS 27 0.0001
965 WEIGHT DECREASED 15 0.0001
966 INSOMNIA 14 0.0001
967 DEHYDRATION 7 0.0001
968 SINUSITIS 5 0.0000
969 ABDOMINAL PAIN UPPER 10 0.0000
970 VISUAL IMPAIRMENT 6 0.0000
971 BLOOD GLUCOSE INCREASED 9 0.0000
972 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
973 HEADACHE 28 0.0000
974 DEVICE ISSUE 4 0.0000
975 PRURITUS 17 0.0000
976 PAIN IN EXTREMITY 13 0.0000
977 FATIGUE 34 0.0000
978 CARDIAC DISORDER 4 0.0000
979 CONTUSION 4 0.0000
980 DYSPEPSIA 4 0.0000
981 BRONCHITIS 3 0.0000
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
983 DECREASED APPETITE 9 0.0000
984 ASTHMA 4 0.0000
985 BALANCE DISORDER 3 0.0000
986 ADVERSE DRUG REACTION 3 0.0000
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
988 ADVERSE EVENT 3 0.0000
989 ABDOMINAL DISCOMFORT 5 0.0000
990 ARTHRALGIA 10 0.0000
991 GAIT DISTURBANCE 4 0.0000
992 INJECTION SITE PAIN 5 0.0000